Details for New Drug Application (NDA): 010976
✉ Email this page to a colleague
The generic ingredient in ENOVID-E 21 is mestranol; norethynodrel. There are eleven drug master file entries for this compound. Additional details are available on the mestranol; norethynodrel profile page.
Summary for 010976
Tradename: | ENOVID-E 21 |
Applicant: | Gd Searle Llc |
Ingredient: | mestranol; norethynodrel |
Patents: | 0 |
Profile for product number 004
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-20 | Strength | 0.075MG;5MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 005
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.15MG;9.85MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 006
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-20 | Strength | 0.1MG;2.5MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription